Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lenalidomide

EU orphan designation number: EU/3/11/868   
Active ingredient: Lenalidomide
Indication: Treatment of diffuse large B-cell lymphoma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Centralised Orphan - Designation EMA/OD/160/10 (2011)3494 of 13/05/2011
30/05/2011 Other procedure EMA/OD/160/10